Clinical Trials Browser

Phase 3 × Immune System Diseases × ibritumomab tiuxetan × Clear all

NCT02366663 2018-03-12

SPINOZA

Immune System Diseases, Immunoproliferative Disorders, Lymphatic Diseases, Lymphoma, Lymphoma, Non-Hodgkin, Lymphoproliferative Disorders, Neoplasms, Neoplasms by Histologic Type, Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse